Cancer Genetics (NASDAQ:CGIX) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a sell rating on the stock. Cancer Genetics Price Performance Shares of NASDAQ:CGIX opened at $0.18 on Friday. The stock has a market capitalization of $736,525.50, a PE ratio of […]
More Stories
Kestrel Gold (CVE:KGC) Shares Down 14.3% – Here’s Why
Kestrel Gold Inc. (CVE:KGC – Get Free Report)’s stock price fell 14.3% on Saturday . The company traded as low...
AutoZone (NYSE:AZO) Price Target Raised to $3,678.00 at Argus
AutoZone (NYSE:AZO – Free Report) had its price objective raised by Argus from $3,560.00 to $3,678.00 in a report released...
Deutsche Bank Aktiengesellschaft Begins Coverage on UP Fintech (NASDAQ:TIGR)
Deutsche Bank Aktiengesellschaft initiated coverage on shares of UP Fintech (NASDAQ:TIGR – Free Report) in a research report report published...
Astera Labs (NASDAQ:ALAB) Lowered to “Hold” Rating by Northland Capmk
Northland Capmk downgraded shares of Astera Labs (NASDAQ:ALAB – Free Report) from a strong-buy rating to a hold rating in...
BWS Financial Begins Coverage on Movado Group (NYSE:MOV)
BWS Financial started coverage on shares of Movado Group (NYSE:MOV – Free Report) in a research report released on Thursday,...
Sidoti Csr Has Negative Forecast for BSET Q1 Earnings
Bassett Furniture Industries, Incorporated (NASDAQ:BSET – Free Report) – Stock analysts at Sidoti Csr reduced their Q1 2025 earnings per...